ADAPY
Adaptimmune Therapeutics Plc - ADR

10,440
Loading...
Loading...
Upcoming Earnings: Q3 '25
Reports: Nov 12,
Pre-Market

Estimated EPS

-$0.12

Estimated Rev

---

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '25
-$0.12
--
--
N/A
Q2 '25
--
-$0.02
--
N/A

Latest ADAPY News

View
No ADAPY news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.